Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504504
Status:
COMPLETED
Last Update Posted:
2013-07-09
First Post:
2007-07-19
Brief Title:
Rituximab and ABVD for Hodgkins Patients
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Hodgkins Disease | View |
| Lymphoma | View |
| Rituximab | View |
| Rituxan | View |
| Adriamycin | View |
| Doxorubicin | View |
| Rubex | View |
| Bleomycin | View |
| Bleomycin sulfate | View |
| Blenoxane | View |
| BLM | View |
| Dacarbazine | View |
| DTIC | View |
| DTIC-Dome | View |
| Vincristine | View |
| Vinblastine | View |
| Vinblastine Sulfate | View |
| ABVD | View |
| ABVD Chemotherapy Treatment | View |